| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/19/2006 | US20060014694 Peptide purification |
| 01/19/2006 | US20060014693 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 01/19/2006 | US20060014680 Peptides of sequence of amino acids where one or more of the peptidyl [ C(O)NR ] linkages (bonds) have been replaced by a non-peptidyl linkage; IL-5 antagonists treating asthma |
| 01/19/2006 | US20060014674 Methods for preparing purified lipopeptides |
| 01/19/2006 | US20060014668 Antigenic gp 100 compounds for therapy and diagnosis and methods of using same |
| 01/19/2006 | US20060014253 Lamprey GnRH-III polypeptides and methods of making thereof |
| 01/19/2006 | US20060014201 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 01/19/2006 | US20060014194 Melanocortin receptor-specific hexapeptides |
| 01/19/2006 | US20060014136 Method of screening for protection from microbial infection |
| 01/19/2006 | US20060013860 Anticancer agents; side effect reduction |
| 01/19/2006 | CA2573400A1 Cyclosporins to treat alzheimer's disease |
| 01/19/2006 | CA2572873A1 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | CA2570396A1 Antibacterial peptides and analogues thereof |
| 01/18/2006 | EP1616956A1 Cell death-inducing fused gene acting specifically on cancer and gene product thereof |
| 01/18/2006 | EP1616954A2 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616875A1 GD3-mimetic peptides |
| 01/18/2006 | EP1616571A2 Lysine containing peptides for treatment of heart disease |
| 01/18/2006 | EP1616024A1 The use of pde4d in the screening for medicaments against atherosclerosis |
| 01/18/2006 | EP1615954A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615653A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 01/18/2006 | EP1511760B1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/18/2006 | EP1252181B1 Peptides with antibacterial activity |
| 01/18/2006 | EP1232183B1 Peptides having antiangiogenic activity |
| 01/18/2006 | EP1127068B1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/18/2006 | EP1071442B9 Methods and compositions for peptide synthesis (t-20) |
| 01/18/2006 | CN1721431A Novel alpha-melanocyte stimulating hormone analogue and use thereof |
| 01/18/2006 | CN1721430A Bacteriophage containing short-peptide specifically combined with avian infectious bronchitis virus and use thereof |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/17/2006 | US6987167 Process for production of the somatostatin analog, octreotide |
| 01/17/2006 | US6987166 Anti-C5a antibodies |
| 01/17/2006 | US6987090 Use of 3-position cyclosporin derivatives for hair growth |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/12/2006 | WO2005110456A3 T-cell death-inducing epitopes |
| 01/12/2006 | US20060009622 inflammatory bowel disease, rheumatoid arthritis, acromegaly, tuberculosis, tumor of the lung, breast, brain, eye, prostate or colon, a tumor of neuroendocrine origin, an angiogenesis disease that causes inappropriate proliferation of blood vessels, retinal macular degeneration or diabetic neuropathy |
| 01/12/2006 | US20060009393 Immunogenic epitopes for fibroblast growth factors 5 (FGF-5) |
| 01/12/2006 | US20060009392 Antineoplastic peptides |
| 01/12/2006 | US20060009391 Method and peptide for regulating cellular activity |
| 01/12/2006 | US20060008848 synthesizing a peptide from a selected number of natural or non-natural amino acids; stabilized p53 donor helical peptides |
| 01/11/2006 | EP1613651A2 Methods and compositions for the inhibition of modulation of t cell costimulatory pathway by a pathogenic agent |
| 01/11/2006 | EP1613646A2 Process for preparation of cyclosporin "a" analogues having a terminal diene group |
| 01/11/2006 | EP1613339A2 Anti-fungal peptidomimetics |
| 01/11/2006 | EP1613338A2 Tamandarin analogs and fragments thereof and methods of making and using |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1179186B1 Method for identifying modulators of interacting proteins |
| 01/11/2006 | EP1165610B1 Peptide useful in treating multiple sclerosis and a pharmaceutical composition comprising the same |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | CN1720260A Process for the preparation of bicyclic peptide compounds |
| 01/11/2006 | CN1720259A Tumor targeting agents and uses thereof |
| 01/11/2006 | CN1720258A Tumor targeting agents and uses thereof |
| 01/10/2006 | US6984718 Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 01/10/2006 | US6984486 Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | US6984373 For diagnosis and therapy of pathological intravascular thrombosis; for detecting, imaging, and localizing thrombi |
| 01/08/2006 | CA2509766A1 Mouse trace amine associated receptors |
| 01/08/2006 | CA2509432A1 Human trace amine associated receptors |
| 01/07/2006 | CA2509632A1 Me-5, me-2, and epp2: human protein antigens reactive with autoantibodies present in the serum of woman suffering from endometriosis |
| 01/05/2006 | WO2006002221A2 Fluorogenic enzyme assays and substrates for kinases and phosphatases |
| 01/05/2006 | WO2006001582A1 Cell-killing peptide |
| 01/05/2006 | WO2006001011A1 Use of mycobacterial mannosylated lipoglycans peptide mimotopes for treating inflammation |
| 01/05/2006 | WO2005066867A3 Modulators of cell-surface receptors of the ig-class |
| 01/05/2006 | WO2005016280A3 Orally administered small peptides synergize statin activity |
| 01/05/2006 | WO2004078146A3 Trans-membrane-antibody induced inhibition of apoptosis |
| 01/05/2006 | WO2003095477A3 Miniprotein ligands and other polypeptides and methods for making and using same |
| 01/05/2006 | US20060004184 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060003940 T-cell death-inducing epitopes |
| 01/05/2006 | US20060003939 Stimulating or accelerating apoptosis by contacting cell with an (Inhibitor of Apoptosis Protein) IAPi-derived peptide having a Trp-box consensus sequence and an RHG amino acid consensus sequence; antitumor, anticarcinogenic and antiinflammatory agents; induces self-ubiquitination; drug screening |
| 01/05/2006 | US20060003938 Novel pyrrhocoricin-derived peptides and methods of use thereof |
| 01/05/2006 | US20060003926 Anticancer, antitumor agents; mixture of metal, drug, peptide and carriers |
| 01/05/2006 | US20060003386 Metallopeptide combinatorial libraries and applications |
| 01/05/2006 | US20060003348 Omi PDZ modulators |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | DE102004026135A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 01/05/2006 | CA2578592A1 Conjugates and therapeutic uses thereof |
| 01/04/2006 | EP1612555A1 Cryptic peptides for use in inducing immunologic tolerance |
| 01/04/2006 | EP1611151A2 Stq-peptides |
| 01/04/2006 | EP1611093A2 Modified transferrin fusion proteins |
| 01/04/2006 | EP1294390B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotection from glutamate toxicity |
| 01/04/2006 | EP1150995B1 A synthetic peptide disturbing intracellular signaling |
| 01/04/2006 | EP0966545B1 Method for typing of minor histocompatibility antigen ha-1 |
| 01/03/2006 | US6982318 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 01/03/2006 | US6982316 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 01/03/2006 | US6982313 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 01/03/2006 | US6982249 using oligopeptides of given sequences to selectively inhibit thrombin-induced platelet and other cell activation |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 12/29/2005 | WO2005123769A1 Hla-a2-binding protein originating in prostate-related antigen |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123761A1 GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION |
| 12/29/2005 | WO2005123760A2 Treating cancer |
| 12/29/2005 | WO2005123759A2 Fgfr binding peptides |
| 12/29/2005 | WO2005082348A3 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism |
| 12/29/2005 | WO2005068492A3 Peptide inhibitors of retroviral integrase useful for the treatment of retroviral infection |
| 12/29/2005 | WO2005042698A3 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |